Participants: Males and females followed over a year.
Parameters: Blood pressure measured initially and post-treatment after administering two different drugs.
Objective: Analyze reduction in blood pressure as the response variable.
Response Variable (y): Reduction in blood pressure.
Defined as the difference in blood pressure measurements before and after treatment.
Predictor Variables:
x1: Drug type (binary predictor)
Drug 1: coded as 1
Drug 2: coded as 0
x2: Gender (binary predictor)
Male: coded as 1
Female: coded as 0
Model: In cases where drug effectiveness is assumed to be similar for both genders, no interaction term is needed:
[ y = \beta_0 + \beta_1x_1 + \beta_2x_2 + \epsilon ]
If there is a suspicion that drug effectiveness may differ by gender, include an interaction term:
Model:
[ y = \beta_0 + \beta_1x_1 + \beta_2x_2 + \beta_3 (x_1 \times x_2) + \epsilon ]
To assess interaction:
Null Hypothesis (H0): ( \beta_3 = 0 ) (no interaction)
Alternative Hypothesis (H1): ( \beta_3
eq 0 ) (interaction present)
If interaction is confirmed, to compare drug effectiveness:
Test: ( \beta_1 = 0 ) and ( \beta_3 = 0 ) vs at least one non-zero
Interaction Definition: Occurs when the effect of one variable depends on another.
Determining Interaction:
If drug effectiveness is consistent across genders, no interaction is needed.
If potential differences exist, interaction terms should be included in the model.
Model incorporating both types:
Predictors: Continuous predictor (x1) and binary predictor (x2 - gender).
Determine signs for coefficients based on modeled relationships:
Beta 1: Slope for females, sign derived from visual model analysis (i.e., upward or downward trend).
Beta 3: Represents the difference between male and female slopes,
Determine by assessing the slopes visually.
Beta 2: The intercept difference between males and females.
Consider real-life scenarios:
Analyze slope for specific predictors in two-way interaction context (e.g., elevation and rainfall).
Assess increases in response under various configurations of predictors with interactions included.
Recognize when interactions are necessary based on assumptions of differences in treatment effects across groups.
Evaluate null and alternative hypotheses relevant to model components, especially interaction terms.
Interpretation of coefficients becomes complex with interactions; careful distinction between main effects and slopes required.